Magnetic Resonance Imaging of the Coronary Vessel Wall
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Despite advances in prevention and treatment, clinical manifestations of atherosclerosis (e.g. myocardial infarction, stroke) remain the largest cause of mortality in the Western world. The occurrence of acute ischemic syndromes, including unstable angina and myocardial infarction, is highly associated with atherosclerotic plaque morphology.
Magnetic resonance (MR) imaging is able to noninvasively depict the lumen of coronary arteries without the need for ionizing radiation. In addition, MR imaging is able to generate soft-tissue contrast unlike any other imaging modality. It has been shown in the aorta and carotid artery that MR imaging is able to identify different atherosclerotic plaque components in vivo. Similar MR imaging techniques are becoming available to visualize the coronary arterial wall and preliminary studies have shown the feasibility of MR coronary vessel wall imaging in humans.
The overall aim of the current study is to identify in vivo MR coronary vessel wall and plaque features that are associated with acute coronary syndromes. This study is divided into 2 substudies:
- Detection of atherosclerosis in the coronary vessel wall with contrast-enhanced MR imaging in patients with coronary artery disease and age-matched healthy volunteers.
- Characterization of coronary vessel wall plaque morphology in patients with stable and unstable angina: validation of MRI with the current standard of reference intravascular ultrasound (IVUS).
| Condition |
|---|
|
Coronary Artery Disease |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Detection of Vulnerable Plaque With Coronary Vessel Wall Magnetic Resonance Imaging |
Eligibility| Ages Eligible for Study: | 18 Years to 90 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
- Patients with (un)stable angina or non-st-elevated myocardial infarction: sample from dept. of cardiology
- healthy volunteers: community sample
Inclusion Criteria:
- patients with (un)stable angina or non-ST-elevated myocardial infarction
- patients are scheduled for, or recently had X-ray coronary angiography
- healthy volunteers, no clinical history of coronary artery disease(control group for substudy 1)
- patients with non-ischemic heart disease, scheduled for X-ray coronary angiography (control group for substudy 2)
- informed consent
Exclusion Criteria:
- severe arrhythmia
- hemodynamic unstable patients
- contra-indications for MRI
Contacts and Locations| Netherlands | |
| Maastricht University Hospital | |
| Maastricht, Netherlands, 6229 HX | |
| Principal Investigator: | Tim Leiner, MD, PhD | Maastricht University Hospital |
More Information
No publications provided by Maastricht University Medical Center
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | T. Leiner, M.D., PhD, Dept. of Radiology, Maastricht University Hospital |
| ClinicalTrials.gov Identifier: | NCT00456950 History of Changes |
| Other Study ID Numbers: | MEC 04-272 |
| Study First Received: | April 4, 2007 |
| Last Updated: | September 23, 2009 |
| Health Authority: | Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) |
Keywords provided by Maastricht University Medical Center:
|
coronary atherosclerosis magnetic resonance imaging vulnerable plaque |
Additional relevant MeSH terms:
|
Coronary Artery Disease Myocardial Ischemia Coronary Disease Heart Diseases |
Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases |
ClinicalTrials.gov processed this record on May 16, 2013